XRK3F2
XRK3F2 is a small molecule inhibitor targeting the p62-ZZ domain. In vitro, it counteracts myeloma-induced suppression of Runx2, a key osteogenic transcription factor. In vivo, it promotes new bone formation and remodeling even in a tumor-bearing microenvironment, making it a valuable research tool for studying bone biology and oncology.
Product Specifications
CAS Number
2375193-43-2
Product Name Alternative
P62-ZZ, P62-ZZ domain, XRK3F2, XRK-3F2
Field of Research
Cell Biology
Purity
98.75% (May vary between batches)
Solubility
H2O:0.8 mg/mL (1.84 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (9.18 mM) ; DMSO:135 mg/mL (309.71 mM)
Smiles
Cl.OCCNCc1ccc (OCc2ccc (F) cc2) c (OCc2ccc (F) cc2) c1
Molecular Formula
C23H24ClF2NO3
Molecular Weight
435.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog